Additionally, Mr. Giarratana recently represented a medical device manufacturer in connection with an equity purchase and related intellectual property license agreement with a major pharmaceutical company. The pharmaceutical company purchased an equity interest in his client's business and Mr. Giarratana negotiated further development and license agreements whereby the parties jointly developed and manufactured the patented and patent-pending technologies.